Oregovomab
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | CA125 |
Clinical data | |
Trade names | OvaRex |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Molar mass | ca. 150 kg/mol |
(what is this?) (verify) |
Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.[1]
This drug was developed by AltaRex Corp.
References
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.
Categories:
- Articles with short description
- Short description is different from Wikidata
- Drugs not assigned an ATC code
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Infobox-drug molecular-weight unexpected-character
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drugs that are a monoclonal antibody
- Monoclonal antibodies for tumors
- Experimental cancer drugs
- All stub articles
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs